Footwear supplier Dr Martens (LON: DOCS) is reporting its full year figures on Wednesday 1 June. Dr Martens floated 16 months ago and got off to an impressive start, going to a significant premium to the placing price of 370p. However, there has been a downward trend in the past 12 months, reaching 209.2p at the end of last week. The results should reassure investors that the decline has been overdone.
In the year to March 2022, revenues are expected to increase from £773m to £906m, while pr...
You are unauthorized to view this page.